Skip to main content
Livermore
Livermore
ZHEN

Dimensional Fund Advisors LP

SEC CIK
0000354204
Latest filing
Aug 11, 2026

RPRX holding history

Royalty Pharma plc in every 13F filed by Dimensional Fund Advisors LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RPRX overviewAll 13F holders of RPRXFull Q2 2026 holdings

Shares (Q2 2026)
1,056,354
Value
$59.3M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of RPRX by Dimensional Fund Advisors LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,056,354$59.3M<0.1%−22,011−2.0%ReducedHolders
Q1 20261,078,365$51.7M<0.1%−1,233,763−53.4%ReducedHolders
Q4 20252,312,128$89.4M<0.1%+211,638+10.1%AddedHolders
Q3 20252,100,490$74.1M<0.1%+205,498+10.8%AddedHolders
Q2 20251,894,992$68.3M<0.1%+179,605+10.5%AddedHolders
Q1 20251,715,387$53.4M<0.1%+34,852+2.1%AddedHolders
Q4 20241,680,535$42.9M<0.1%+580,787+52.8%AddedHolders
Q3 20241,099,748$31.1M<0.1%+312,491+39.7%AddedHolders
Q2 2024787,257$20.8M<0.1%+139,761+21.6%AddedHolders
Q1 2024647,496$19.7M<0.1%+18,927+3.0%AddedHolders
Q4 2023628,569$17.7M<0.1%+126,705+25.2%AddedHolders
Q3 2023501,864$13.6M<0.1%+99,317+24.7%AddedHolders
Q2 2023402,547$12.4M<0.1%+12,588+3.2%AddedHolders
Q1 2023389,959$14.1M<0.1%+64,882+20.0%AddedHolders
Q4 2022325,077$12.8M<0.1%−10,362−3.1%ReducedHolders
Q3 2022335,439$13.5M<0.1%+42,479+14.5%AddedHolders
Q2 2022292,960$12.3M<0.1%+8,019+2.8%AddedHolders
Q1 2022284,941$11.1M<0.1%+54,740+23.8%AddedHolders
Q4 2021230,201$9.17M<0.1%+69,686+43.4%AddedHolders
Q3 2021160,515$5.80M<0.1%+151,369+1,655.0%AddedHolders
Q2 20219,146$375.0K<0.1%−295−3.1%ReducedHolders
Q1 20219,441$413.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.